Detalhe da pesquisa
1.
Environmental Impact Assessment for the Use of an Orally Aerosolized Adenovirus Type-5 Vector-Based COVID-19 Vaccine in Randomized Clinical Trials.
J Infect Dis;
228(6): 715-722, 2023 09 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37202147
2.
Comparison of antibody persistency through one year between one-dose and two-dose regimens of Ad5-nCoV vaccine for COVID-19.
Hum Vaccin Immunother;
19(2): 2230760, 2023 08 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37428653